Why Legend Biotech Corp ADR (NASDAQ:LEGN) Stock fell -31.12% in Last Six Months?

Scotiabank raised the price target for the Legend Biotech Corp ADR (NASDAQ:LEGN) stock from “a Sector perform” to “a Sector outperform”. The rating was released on April 17, 2024, according to finviz. The research report from Raymond James has initiated the stock to Outperform, with a price target set at $86. In their research brief […]

It’s an all-out bull run for Legend Biotech Corp ADR (LEGN) Stock

Scotiabank raised the price target for the Legend Biotech Corp ADR (NASDAQ:LEGN) stock from “a Sector perform” to “a Sector outperform”. The rating was released on April 17, 2024, according to finviz. The research report from Raymond James has initiated the stock to Outperform, with a price target set at $86. In their research brief […]

In the current cycle, Legend Biotech Corp ADR (LEGN) Stock is showing signs of growth

Scotiabank raised the price target for the Legend Biotech Corp ADR (NASDAQ:LEGN) stock from “a Sector perform” to “a Sector outperform”. The rating was released on April 17, 2024, according to finviz. The research report from Raymond James has initiated the stock to Outperform, with a price target set at $86. In their research brief […]

Legend Biotech Corp ADR (LEGN) Stock: Values And Value Intersection

Scotiabank raised the price target for the Legend Biotech Corp ADR (NASDAQ:LEGN) stock from “a Sector perform” to “a Sector outperform”. The rating was released on April 17, 2024, according to finviz. The research report from Raymond James has initiated the stock to Outperform, with a price target set at $86. In their research brief […]

Is Legend Biotech Corp ADR (LEGN) Stock A Better Investment Than Its Rivals?

Scotiabank raised the price target for the Legend Biotech Corp ADR (NASDAQ:LEGN) stock from “a Sector perform” to “a Sector outperform”. The rating was released on April 17, 2024, according to finviz. The research report from Raymond James has initiated the stock to Outperform, with a price target set at $86. In their research brief […]

The Underside Of Legend Biotech Corp ADR (LEGN) Stock Is A Little Uncertain

Cantor Fitzgerald raised the price target for the Legend Biotech Corp ADR (NASDAQ:LEGN) stock to “an Overweight”. The rating was released on April 03, 2024, according to finviz. The stock was initiated by Goldman, who disclosed in a research note on November 06, 2023, to Buy and set the price objective to $90.09. In their […]